Arkolith/Insider Trading/MREO/Form 4

Lewicki John A.

Chief Scientific OfficerMereo BioPharma Group plc (MREO) · full profile →Form 4 · filed Jun 27, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$84K
Net Open-Market Flow
-$84K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2024Sell(S)17K$3.39$57K49K
Jun 25, 2024Sell(S)7K$3.69$27K66K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-078468) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML